LRP8 promotes tumorigenesis in ovarian cancer through inhibiting p53 signaling

This study confirmed that LRP8/p53 axis contributed to OC progression, which might serve as a novel potential therapeutic target for OC patients.PMID:38263609 | DOI:10.1002/cbin.12133

Source: Cell Biology International - January 24, 2024 Category: Cytology Authors: Yan Xu Yang Zhou Xiling Yi Xiaocui Nie Source Type: research